SEC investigates allegations of misspending by Dow Chemical CEO
The U.S. Securities and Exchange Commission is investigating allegations that Andrew Liveris, chairman and chief executive officer of industrial giant Dow Chemical Co, misused company funds for personal benefit, according to people familiar with the matter.